Economic analyses of breast cancer control in low- and middle-income countries: a systematic review

scientific article published on April 8, 2013

Economic analyses of breast cancer control in low- and middle-income countries: a systematic review is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1042020459
P356DOI10.1186/2046-4053-2-20
P953full work available at URLhttp://link.springer.com/article/10.1186/2046-4053-2-20/fulltext.html
http://link.springer.com/content/pdf/10.1186/2046-4053-2-20
http://link.springer.com/content/pdf/10.1186/2046-4053-2-20.pdf
https://europepmc.org/articles/PMC3651267
https://europepmc.org/articles/PMC3651267?pdf=render
https://systematicreviewsjournal.biomedcentral.com/track/pdf/10.1186/2046-4053-2-20
P932PMC publication ID3651267
P698PubMed publication ID23566447
P5875ResearchGate publication ID236138000

P2093author name stringRob M. Baltussen
Sten G. Zelle
P2860cites workLow cost of cancer detection in the first year of mammographic screening in PolandQ51853795
Retrospective cost-effectiveness analysis of screening mammographyQ53241570
Screening for breast cancerQ69223355
International trends in the economics of breast examinationQ70224657
Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumoniaQ71325040
Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesityQ81581720
The good news about cancer in developing countriesQ82354160
Screening for breast cancer in Iran: a challenge for health policy makersQ82561162
Breast screening: the facts--or maybe notQ83251265
Cytopathology Including Fine-Needle Aspiration in Sub-Saharan Africa: A Cameroon ExperienceQ83338540
Expenditure audit of women with breast cancer in a tertiary care hospital of DelhiQ83368809
Methodological issues in cost-effectiveness studies: a brief overviewQ83471199
Resource-sparing and cost-effective strategies in current management of breast cancerQ84097261
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in EnglandQ24629668
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Q27860674
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco controlQ30485941
Cost-effective screening for breast cancer worldwide: current state and future directionsQ30488485
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry dataQ33779753
A tool to improve quality of reporting published economic analysesQ33920992
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality databaseQ34061266
Estimation of the cost of treatment by chemotherapy for early breast cancer in MoroccoQ34142012
Priority actions for the non-communicable disease crisisQ34176583
Breast Cancer: A Neglected Disease for the Majority of Affected Women WorldwideQ34949553
Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysisQ35798038
Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling studyQ35798048
Generalisability in economic evaluation studies in healthcare: a review and case studies.Q35950554
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force reportQ36263674
Bias in clinical intervention research.Q36380552
Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working PartyQ36599584
The burden and costs of chronic diseases in low-income and middle-income countriesQ37026095
Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global InitiativeQ37849954
Establishing an evidence-base for breast cancer control in developing countriesQ37858212
Breast cancer early detection methods for low and middle income countries, a review of the evidenceQ37979916
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010.Q38423916
Cost-effectiveness of clinical breast assessment-based screening in rural Egypt.Q38970025
The costs of breast cancer prior to and following diagnosisQ39889963
Continuing declines in cancer mortality in the European UnionQ40260959
Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: doxorubicin plus cyclophosphamide versus docetaxel plus cyclophosphamide.Q43267099
Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in BrazilQ43277240
Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancerQ43993886
Breast cancer screening policies in developing countries: a cost-effectiveness analysis for IndiaQ44067048
Cost-utility analysis of adjuvant therapies for breast cancer in Iran.Q44401570
Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited settingQ44878875
Breast and Prostate Cancer Productivity Costs: A Comparison of the Human Capital Approach and the Friction Cost ApproachQ45951626
The Cost-effectiveness of Mammographic Screening StrategiesQ46242452
Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and AsiaQ46573606
Mammographic Screening and “Overdiagnosis”Q46683429
Fine needle aspiration (FNA) in the management of palpable masses in Ibadan: impact on the cost of careQ46800453
Costs, effects and cost-effectiveness of breast cancer control in GhanaQ47371218
Marking non-palpable breast masses with injected methylene blue dye, an easy, safe and low cost method for developing countries and resource-limited areasQ48235390
Breast cancer screening; cost-effective in practice?Q50139380
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectglobal healthQ2725393
breast neoplasmQ23929670
mass screeningQ64733553
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)20
P577publication date2013-04-08
P13046publication type of scholarly worksystematic reviewQ1504425
P1433published inSystematic ReviewsQ18216009
P1476titleEconomic analyses of breast cancer control in low- and middle-income countries: a systematic review
P478volume2

Reverse relations

cites work (P2860)
Q36036440A Systematic Review of Health Economic Analyses of Housing Improvement Interventions and Insecticide-Treated Bednets in the Home
Q27005964A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
Q41486867Cancer control capacity in 50 low- and middle-income countries
Q89967674Cost-Effectiveness of Lifestyle-Related Interventions for the Primary Prevention of Breast Cancer: A Rapid Review
Q35070383Cost-effectiveness analysis of breast cancer control interventions in Peru
Q26795628Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries
Q27013654Implementation science in cancer prevention and control: a framework for research and programs in low- and middle-income countries
Q46928725Improving women's health in low-income and middle-income countries. Part II: the needs of diagnostic imaging.
Q43866899Predicting the stage shift as a result of breast cancer screening in low- and middle-income countries: a proof of concept
Q27027277Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal
Q36270293Refining a questionnaire to assess breast cancer knowledge and barriers to screening in Kenya: Psychometric assessment of the BCAM.
Q35665603Systematic Review and Quality Appraisal of Economic Evaluation Publications in Dentistry
Q90377048Systematic reviews as a "lens of evidence": Determinants of cost-effectiveness of breast cancer screening

Search more.